Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

United Therapeutics buy Cantor Fitzgerald

Start price
€268.10
14.08.25 / 50%
Target price
-
14.08.26
Performance (%)
52.89%
Price
€409.90
09.12.25
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for United Therapeutics has seen massive gains of 52.89%. This prediction currently runs until 14.08.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
United Therapeutics 0.490% 0.490%
iShares Core DAX® 1.659% 1.586%
iShares Nasdaq 100 0.381% 1.900%
iShares Nikkei 225® 2.102% -1.377%
iShares S&P 500 0.221% 1.258%

Comments by Cantor_Fitzgerald for this prediction

In the thread United Therapeutics diskutieren

United Therapeutics Corporation (NASDAQ: UTHR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for UTHR provided by MarketBeat

Stopped prediction by Cantor_Fitzgerald for United Therapeutics

buy
United Therapeutics

Start price
Target price
Perf. (%)
€341.80
10.09.25
€448.82
10.09.26
19.92%
09.12.25

buy
United Therapeutics

Start price
Target price
Perf. (%)
€283.30
02.06.25
€356.20
02.06.26
44.69%
09.12.25